// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Use of electron tomography to confirm the diagnosis of primary ciliary dyskinesia

Amelia Shoemark - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary ciliary dyskinesia

N/A

Quality of life in patients with primary ciliary dyskinesia: a systematic review

Jane Lucas - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary ciliary dyskinesia

N/A

Early-life respiratory tract infections and the risk of lower lung function and asthma:a meta-analysis of 154,492 children

Evelien R. van Meel - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

Lean body mass is positively associated with lung function at age 15

Gabriela Prado Peralta - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Obesity

N/A

Primary ciliary dyskinesia exhibits dysregulated epithelial responses to non-typeable Haemophilus influenzae

Jane Lucas - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Primary ciliary dyskinesia

N/A

Respiratory morbidity after hospitalisation with Respiratory Syncytial Virus and Rhinovirus infection

Pearl Ampah - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

How do differences in absolute lung volumes contribute to ethnic differences in spirometry?

Nidhal Gharbawi - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Significant inconsistencies in the agreement of children’s respiratory rate measurements between different observers

Will Daw - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

What is the minimum duration of nocturnal oximetry to screen for obstructive sleep apnoea in children?

Niamh Galway - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Sleep apnoea

N/A

Physical activity levels in a severe asthma population

Rebecca Livingston - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Asthma

N/A

The views of health care providers’ (HCPs) and patients with Chronic Obstructive Pulmonary Disease (COPD) on pain in pulmonary rehabilitation (PR): A qualitative study

Samantha Harrison - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Relation between training quality, improvements in inspiratory muscle function, and changes in exercise capacity following an inspiratory muscle training intervention (IMTCO study)

Noppawan Charususin - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The use of the Nijmegen Questionnaire in assessment of breathing pattern disorders in COPD

Ruth De Vos - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Evaluating the use of the CoughAssist E70 by inpatient physiotherapists

Rebecca Davies - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Striving to improve the efficiency of our exercise service: A quality improvement project

Sarah Akers - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Rolling versus Cohort Pulmonary Rehabilitation – Which is Better!

Lynsey Wright - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Relevance of respiratory secretion related outcomes measures in palliative care

Juliano Ferreira Arcuri - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Rhythm and song: Breath management in Idiopathic Interstitial Pneumonias (IIP's). Pilot study

Anne-Marie Russell - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic interstitial pneumonias

N/A

The challenge of learning motivational interviewing (MI) for pulmonary rehabilitation (PR): clinician perspectives

Robert Shannon - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Acquiring skills in motivational interviewing (MI) to enhance adherence to pulmonary rehabilitation (PR)

Robert Shannon - European Respiratory Society (ERS) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved